Procaps Group SA

Company Profile

Procaps Group SA had its IPO on 2021-09-30 under the ticker symbol PROC.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Procaps Group SA has a staff strength of 5,500 employees.

Stock update

Shares of Procaps Group SA opened at $3.8 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.7 - $3.8, and closed at $3.7.

This is a 0% increase from the previous day's closing price.

A total volume of 1,791 shares were traded at the close of the day’s session.

In the last one week, shares of Procaps Group SA have slipped by -6.57%.

Procaps Group SA's Key Ratios

Procaps Group SA has a market cap of $446.78 million, indicating a price to book ratio of 0 and a price to sales ratio of 1.6081.

In the last 12-months Procaps Group SA’s revenue was $408.45 million with a gross profit of $191.31 million and an EBITDA of $63.71 million. The EBITDA ratio measures Procaps Group SA's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Procaps Group SA’s operating margin was 13.69% while its return on assets stood at 7.56% with a return of equity of 46.32%.

In Q2, Procaps Group SA’s quarterly earnings growth was a negative -59.7% while revenue growth was a negative 1.7%.

Procaps Group SA’s PE and PEG Ratio

Forward PE

13.2979

Trailing PE

12

PEG

Its diluted EPS in the last 12-months stands at $0.33 per share while it has a forward price to earnings multiple of 13.2979 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Procaps Group SA’s profitability.

Procaps Group SA stock is trading at a EV to sales ratio of 2.1421 and a EV to EBITDA ratio of 58.2808. Its price to sales ratio in the trailing 12-months stood at 1.6081.

Procaps Group SA stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$490.72 million

Total Liabilities

$243.88 million

Operating Cash Flow

$0

Capital Expenditure

$7.86 million

Dividend Payout Ratio

0%

Procaps Group SA ended 2024 with $490.72 million in total assets and $0 in total liabilities. Its intangible assets were valued at $490.72 million while shareholder equity stood at $32.96 million.

Procaps Group SA ended 2024 with $0 in deferred long-term liabilities, $243.88 million in other current liabilities, 1011000.00 in common stock, $-362432000.00 in retained earnings and $5.79 million in goodwill. Its cash balance stood at $11.54 million and cash and short-term investments were $19.97 million. The company’s total short-term debt was $118,684,000 while long-term debt stood at $169.64 million.

Procaps Group SA’s total current assets stands at $295.55 million while long-term investments were $8.19 million and short-term investments were $8.43 million. Its net receivables were $169.59 million compared to accounts payable of $85.97 million and inventory worth $103.48 million.

In 2024, Procaps Group SA's operating cash flow was $0 while its capital expenditure stood at $7.86 million.

Comparatively, Procaps Group SA paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$3.7

52-Week High

$7.75

52-Week Low

$3.55

Analyst Target Price

$7

Procaps Group SA stock is currently trading at $3.7 per share. It touched a 52-week high of $7.75 and a 52-week low of $7.75. Analysts tracking the stock have a 12-month average target price of $7.

Its 50-day moving average was $3.97 and 200-day moving average was $4.53 The short ratio stood at 2.76 indicating a short percent outstanding of 0%.

Around 8302.8% of the company’s stock are held by insiders while 295% are held by institutions.